Activating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma.
about
ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma.Silencing activating transcription factor 2 promotes the anticancer activity of sorafenib in hepatocellular carcinoma cells.Downregulation of histone demethylase JMJD1C inhibits colorectal cancer metastasis through targeting ATF2.miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2.SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
P2860
Activating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Activating transcription facto ...... non-small cell lung carcinoma.
@en
type
label
Activating transcription facto ...... non-small cell lung carcinoma.
@en
prefLabel
Activating transcription facto ...... non-small cell lung carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Activating transcription facto ...... non-small cell lung carcinoma.
@en
P2093
Shaoqing Chen
Wenyan Chen
Xiaolang Wang
Yuling Guo
Zhenyu You
P2860
P304
P356
10.3892/OL.2015.3922
P577
2015-11-16T00:00:00Z